Voyageur Pharmaceuticals (CVE:VM) Stock Price Up 24.2% – Still a Buy?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) shares were up 24.2% during mid-day trading on Thursday . The stock traded as high as C$0.21 and last traded at C$0.21. Approximately 280,394 shares were traded during mid-day trading, a decline of 48% from the average daily volume of 537,707 shares. The stock had previously closed at C$0.17.

Voyageur Pharmaceuticals Trading Down 10.0 %

The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21. The company has a market capitalization of C$25.10 million, a P/E ratio of -18.00 and a beta of 0.32. The business has a fifty day moving average price of C$0.11 and a 200 day moving average price of C$0.08.

Voyageur Pharmaceuticals Company Profile

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Read More

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.